drugset / Trial / NCT00991276

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

NCT00991276

Phase 3 Completed 85 enrolled Viatris Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of pregabalin and pramipexole versus placebo in the treatment of restless legs syndrome and associated sleep disturbance.

Timeline

Start
2009-12
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pramipexole Unknown 0.5 mg
Subject Pregabalin Small molecule 300 mg